6-136278253-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 3P and 12B. PM2PP2BP4_StrongBP6_Very_Strong
The NM_014739.3(BCLAF1):c.628G>A(p.Gly210Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000163 in 1,603,494 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00098 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000080 ( 0 hom. )
Consequence
BCLAF1
NM_014739.3 missense
NM_014739.3 missense
Scores
2
7
9
Clinical Significance
Conservation
PhyloP100: 4.13
Genes affected
BCLAF1 (HGNC:16863): (BCL2 associated transcription factor 1) This gene encodes a transcriptional repressor that interacts with several members of the BCL2 family of proteins. Overexpression of this protein induces apoptosis, which can be suppressed by co-expression of BCL2 proteins. The protein localizes to dot-like structures throughout the nucleus, and redistributes to a zone near the nuclear envelope in cells undergoing apoptosis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant where missense usually causes diseases, BCLAF1
BP4
Computational evidence support a benign effect (MetaRNN=0.0066773593).
BP6
Variant 6-136278253-C-T is Benign according to our data. Variant chr6-136278253-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 402423.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BCLAF1 | NM_014739.3 | c.628G>A | p.Gly210Ser | missense_variant | 4/13 | ENST00000531224.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BCLAF1 | ENST00000531224.6 | c.628G>A | p.Gly210Ser | missense_variant | 4/13 | 1 | NM_014739.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000976 AC: 146AN: 149540Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
146
AN:
149540
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0104 AC: 2550AN: 246102Hom.: 0 AF XY: 0.0103 AC XY: 1363AN XY: 132816
GnomAD3 exomes
AF:
AC:
2550
AN:
246102
Hom.:
AF XY:
AC XY:
1363
AN XY:
132816
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000798 AC: 116AN: 1453836Hom.: 0 Cov.: 32 AF XY: 0.0000719 AC XY: 52AN XY: 723224
GnomAD4 exome
AF:
AC:
116
AN:
1453836
Hom.:
Cov.:
32
AF XY:
AC XY:
52
AN XY:
723224
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000976 AC: 146AN: 149658Hom.: 0 Cov.: 32 AF XY: 0.00115 AC XY: 84AN XY: 73152
GnomAD4 genome
AF:
AC:
146
AN:
149658
Hom.:
Cov.:
32
AF XY:
AC XY:
84
AN XY:
73152
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
2445
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 10, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - 5% MAF in Finnish population. Both parents carry this variant in the heterozygous state - variants in this gene are unlikely to be related to patient phenotype. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.;.;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;.;D;D
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;.;N;.;.;.;.
MutationTaster
Benign
D;D;D;D;D;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N;N;N;N;.;N
REVEL
Uncertain
Sift
Pathogenic
D;D;D;D;D;D;.;.
Sift4G
Benign
T;T;T;T;T;T;T;.
Polyphen
D;D;.;D;D;D;.;.
Vest4
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at